Lu-177 based cancer therapies
Lu-177, an innovative radioisotope used in targeted cancer treatments like PRRT, shows significant promise in specialized therapies for neuroendocrine and prostate cancers.
Lu-177, an innovative radioisotope used in targeted cancer treatments like PRRT, shows significant promise in specialized therapies for neuroendocrine and prostate cancers.
Explore the essentials of hydrodynamic entrance length, its calculation, impact on fluid flow, and practical applications in engineering.
Unlock the potential of high-resolution PET imaging to visualize biochemical changes at a cellular level with improved clarity and detail.
Radioisotope clearance studies are medical tests using radioactive substances to assess organ functionality and blood flow dynamics.
Learn about Tc-99m MAG3 renal imaging, a nuclear medicine technique for assessing kidney function and structure using the radioisotope technetium-99m.
Radiocontrast agents enhance medical imaging by improving the visibility of internal body structures, aiding in accurate diagnosis.
Tumor receptor imaging is a critical diagnostic technique that identifies specific molecular targets on cancer cells, aiding in the effective management and treatment of cancer.
A detailed exploration of P-glycoprotein imaging, its role in detecting and studying cancer MDR, and its implications for improving treatment approaches.
Understanding the use of F-18 fluorinated amino acids in PET scanning to visualize amino acid metabolism and detect tumors.
Learn how PET scans use radiotracer technology to monitor and diagnose cancer, neurological disorders, and heart diseases effectively.